Trials / Conditions / Leptomeningeal Carcinomatosis
Leptomeningeal Carcinomatosis
5 registered clinical trials studyying Leptomeningeal Carcinomatosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | ANG1005 in Leptomeningeal Disease From Breast Cancer NCT03613181 | Angiochem Inc | Phase 3 |
| Completed | Ipilimumab and Nivolumab in Leptomeningeal Metastases NCT02939300 | Massachusetts General Hospital | Phase 2 |
| Terminated | A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-sm NCT00830245 | Clinical Research Center for Solid Tumor, Korea | Phase 2 |
| Terminated | A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis NCT00527410 | Biogen | Phase 1 |
| No Longer Available | Expanded Access to ANG1005 for Individual Patients NCT02755987 | Angiochem Inc | — |